{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:04:13Z","timestamp":1789387453432,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.path.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T19:46:08Z","timestamp":1621453568000},"page":"237-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Connective Tissue Diseases in the Skin"],"prefix":"10.1016","volume":"14","author":[{"given":"Carole","family":"Bitar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2021.03.003_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The cutaneous spectrum of lupus erythematosus","volume":"53","author":"Ribero","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.007","article-title":"A\u00a0comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus","volume":"93","author":"Li","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.path.2021.03.003_bib5","first-page":"81","article-title":"Cutaneous lupus erythematosus: current and future pathogenesis-directed therapies","volume":"93","author":"Little","year":"2020","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.path.2021.03.003_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/08916934.2013.866105","article-title":"Ultraviolet B irradiation induces skin accumulation of plasmacytoid dendritic cells: a possible role for chemerin","volume":"47","author":"Yin","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.path.2021.03.003_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jamadermatol.2013.8354","article-title":"Autoantibodies and disease activity in patients with discoid lupus erythematosus","volume":"150","author":"Kim","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","article-title":"The role of neutrophil extracellular traps in rheumatic diseases","volume":"14","author":"Apel","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.path.2021.03.003_bib9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.path.2021.03.003_bib10","doi-asserted-by":"crossref","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.path.2021.03.003_bib11","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.1700778","article-title":"Netting neutrophils activate autoreactive B cells in lupus","volume":"200","author":"Gestermann","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/exd.14040","article-title":"Investigating the presence of neutrophil extracellular traps in cutaneous lesions of different subtypes of lupus erythematosus","volume":"28","author":"Rafi","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.3643","article-title":"A\u00a0gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases","volume":"18","author":"Liang","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib14","doi-asserted-by":"crossref","first-page":"e127291","DOI":"10.1172\/jci.insight.127291","article-title":"The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity","volume":"4","author":"Billi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.path.2021.03.003_bib15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1600-0560.2010.01587.x","article-title":"Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus","volume":"37","author":"Tomasini","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/cup.12416","article-title":"Plasmacytoid dendritic cells in hypertrophic discoid lupus erythematosus: an objective evaluation of their diagnostic value","volume":"42","author":"Walsh","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-0560.2011.01779.x","article-title":"Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining","volume":"38","author":"Ko","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2014.01.892","article-title":"Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells","volume":"71","author":"Brown","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaad.2015.12.050","article-title":"Clusters of CD123+ plasmacytoid dendritic cells help distinguish lupus alopecia from lichen planopilaris","volume":"74","author":"Kolivras","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.abd.2019.11.005","article-title":"Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining","volume":"95","author":"Rakhshan","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/his.13817","article-title":"Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma","volume":"74","author":"Chen","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2021.03.003_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/DAD.0000000000000945","article-title":"Comparative analysis of chilblain lupus erythematosus and idiopathic perniosis: histopathologic features and immunohistochemistry for CD123 and CD30","volume":"40","author":"Wang","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2021.03.003_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0781.2007.00267.x","article-title":"Plasmacytoid dendritic cells are absent in skin lesions of polymorphic light eruption","volume":"23","author":"Wackernagel","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.path.2021.03.003_bib24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/his.12105","article-title":"The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T cell lymphoma","volume":"62","author":"Liau","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2021.03.003_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1600-0560.2006.00559.x","article-title":"Non-bullous neutrophilic dermatosis: an uncommon dermatologic manifestation in patients with lupus erythematosus","volume":"33","author":"Gleason","year":"2006","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2009.05.019","article-title":"Nonbullous neutrophilic lupus erythematosus: a newly recognized variant of cutaneous lupus erythematosus","volume":"66","author":"Brinster","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40257-014-0098-0","article-title":"Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment","volume":"15","author":"Contestable","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","article-title":"Cutaneous manifestations of dermatomyositis: a comprehensive review","volume":"53","author":"Mainetti","year":"2017","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-020-00502-6","article-title":"Dermatomyositis: an update on diagnosis and treatment","volume":"21","author":"Cobos","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib31","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/bjd.15607","article-title":"The pathogenesis of dermatomyositis","volume":"179","author":"Thompson","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2021.03.003_bib33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0000000000000328","article-title":"New developments in genetics of myositis","volume":"28","author":"Rothwell","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.path.2021.03.003_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/acr2.1011","article-title":"Interferon chemokine score and other cytokine measures track with changes in disease activity in patients with juvenile and adult dermatomyositis","volume":"1","author":"Crowson","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.path.2021.03.003_bib35","doi-asserted-by":"crossref","first-page":"e139558","DOI":"10.1172\/jci.insight.139558","article-title":"IL-18-containing five-gene signature distinguishes histologically identical dermatomyositis and lupus erythematosus skin lesions","volume":"5","author":"Tsoi","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.path.2021.03.003_bib36","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/art.22205","article-title":"HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies","volume":"54","author":"O'Hanlon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.path.2021.03.003_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","article-title":"Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies","volume":"20","author":"Wolstencroft","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.path.2021.03.003_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.09.004","article-title":"Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis","volume":"40","author":"Komura","year":"2005","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.path.2021.03.003_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/rheumatology\/kez572","article-title":"Anti-TIF1-\u03b3 autoantibodies: warning lights of a tumour autoantigen","volume":"59","author":"De Vooght","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.path.2021.03.003_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaad.2017.12.010","article-title":"Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features","volume":"78","author":"Kurtzman","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","article-title":"Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus","volume":"35","author":"McNiff","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/DAD.0000000000000701","article-title":"Gottron papules show histopathologic features of localized lymphedema","volume":"39","author":"Fernandez-Flores","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2021.03.003_bib44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaad.2017.10.034","article-title":"Re-examining mechanic's hands as a characteristic skin finding in dermatomyositis","volume":"78","author":"Concha","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/cup.12733","article-title":"Wong-type dermatomyositis: a mimic of many dermatoses","volume":"43","author":"Mutasim","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000371573","article-title":"Wong-type dermatomyositis showing porokeratosis-like changes (columnar dyskeratosis): a case report and review of the literature","volume":"2","author":"Umanoff","year":"2015","journal-title":"Dermatopathology (Basel)"},{"key":"10.1016\/j.path.2021.03.003_bib47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/jdv.14932","article-title":"Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases","volume":"32","author":"Santos-Briz","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.path.2021.03.003_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","article-title":"Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review","volume":"53","author":"Ferreli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib49","doi-asserted-by":"crossref","first-page":"E4985","DOI":"10.3390\/ijms21144985","article-title":"Role of alarmins in the pathogenesis of systemic sclerosis","volume":"21","author":"Giovannetti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.path.2021.03.003_bib50","first-page":"208","article-title":"Scleroderma with an update about clinico-pathological correlation","volume":"153","author":"Rongioletti","year":"2018","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.path.2021.03.003_bib51","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.path.2021.03.003_bib52","doi-asserted-by":"crossref","first-page":"e0154255","DOI":"10.1371\/journal.pone.0154255","article-title":"Human leukocyte antigen and systemic sclerosis in Japanese: the sign of the four independent protective alleles, DRB1\u221713:02, DRB1\u221714:06, DQB1\u221703:01, and DPB1\u221702:01","volume":"11","author":"Furukawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.path.2021.03.003_bib53","doi-asserted-by":"crossref","first-page":"e0126727","DOI":"10.1371\/journal.pone.0126727","article-title":"HLA class I and II blocks are associated to susceptibility, clinical subtypes and autoantibodies in Mexican systemic sclerosis (SSc) patients","volume":"10","author":"Rodriguez-Reyna","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.path.2021.03.003_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.path.2021.03.003_bib55","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","article-title":"Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway","volume":"44","author":"Sambo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.path.2021.03.003_bib56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.path.2021.03.003_bib57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/DAD.0000000000001177","article-title":"The \u201cline sign\u201d is a rapid and efficient diagnostic \u201ctest\u201d for morphea: clinicopathological study of 73 cases","volume":"40","author":"Yang","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2021.03.003_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cup.12242","article-title":"Perineural inflammation in morphea (localized scleroderma): systematic characterization of a poorly recognized but potentially useful histopathological feature","volume":"41","author":"Dhaliwal","year":"2014","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/DAD.0b013e3182712d1a","article-title":"Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration","volume":"35","author":"de-S\u00e1-Earp","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2021.03.003_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000246821","article-title":"Mucin deposits in morphea and systemic scleroderma","volume":"189","author":"Rongioletti","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.path.2021.03.003_bib61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199806000-00003","article-title":"Histopathologic differentiation between localized and systemic scleroderma","volume":"20","author":"Torres","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2021.03.003_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaad.2017.06.148","article-title":"Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: a comparative study of 27 cases","volume":"78","author":"Onajin","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2021.03.003_bib63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cup.12947","article-title":"Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis\u2014a potential marker for histopathologic distinction from morphea","volume":"44","author":"Moy","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2021.03.003_bib64","first-page":"136","article-title":"Undifferentiated connective tissue disease, mixed connective tissue disease, and overlap syndromes in rheumatology","volume":"113","author":"Pepmueller","year":"2016","journal-title":"Mo Med"},{"key":"10.1016\/j.path.2021.03.003_bib65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5114\/reum.2015.51509","article-title":"U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue disease. Part I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease","volume":"53","author":"Paradowska-Gorycka","year":"2015","journal-title":"Reumatologia"},{"key":"10.1016\/j.path.2021.03.003_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/tan.12698","article-title":"Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients","volume":"87","author":"Paradowska-Gorycka","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.path.2021.03.003_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5114\/reum.2015.53136","article-title":"U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue disease. Part II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease","volume":"53","author":"Paradowska-Gorycka","year":"2015","journal-title":"Reumatologia"},{"key":"10.1016\/j.path.2021.03.003_bib68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/030097401753180363","article-title":"Longitudinal study of interleukin-10, tumor necrosis factor- \u03b1, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease","volume":"30","author":"Hassan","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.path.2021.03.003_bib69","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","article-title":"Distinct phenotypes in mixed connective tissue disease: subgroups and survival","volume":"21","author":"Szodoray","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.path.2021.03.003_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2014.01.008","article-title":"The diagnosis and classification of mixed connective tissue disease","volume":"48-49","author":"Tani","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.path.2021.03.003_bib71","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000372-199706000-00002","article-title":"Mixed connective tissue disease: a clinical, histologic, and immunofluorescence study of eight cases","volume":"19","author":"Magro","year":"1997","journal-title":"Am J Dermatopathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918121000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918121000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:42:48Z","timestamp":1761748968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918121000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1875918121000209"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2021.03.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connective Tissue Diseases in the Skin","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}